Rifaximin

Samar Ojaimi; Tony M. Korman

Rifaximin

Samar Ojaimi
, Tony M. Korman

Research output: Chapter in Book/Report/Conference proceeding › Chapter (Book) › Other › peer-review

Abstract

Rifaximin (4-deoxy-4'-methylpyrido[1',2'-1,2]imidazole- [5,4c]-rifamycin SV) is a synthetic antimicrobial and derivative of rifamycin (Jiang and DuPont, 2005; Scarpignato and Pelosini, 2005; Finegold et al., 2009). It was first described as compound L-105 in 1982 and marketed in Italy in 1987 (Huang and DuPont, 2005; Scarpignato and Pelosini, 2005). Its empirical formula is C₄₃H₅₁N₃O₁₁ and its molecular weight is 785.9 Da; the chemical structure is shown in Figure 128.1.

Original language	English
Title of host publication	Kucers the Use of Antibiotics
Subtitle of host publication	A Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs
Editors	M. Lindsay Grayson
Place of Publication	Boca Raton FL USA
Publisher	CRC Press
Chapter	128
Pages	2450-2462
Number of pages	13
Edition	7th
ISBN (Electronic)	9781498747967
ISBN (Print)	9781498747950
Publication status	Published - 2 Oct 2017

Cite this

@inbook{cedcf61b8fca49fcb2062c08016459b2,

title = "Rifaximin",

abstract = "Rifaximin (4-deoxy-4'-methylpyrido[1',2'-1,2]imidazole- [5,4c]-rifamycin SV) is a synthetic antimicrobial and derivative of rifamycin (Jiang and DuPont, 2005; Scarpignato and Pelosini, 2005; Finegold et al., 2009). It was first described as compound L-105 in 1982 and marketed in Italy in 1987 (Huang and DuPont, 2005; Scarpignato and Pelosini, 2005). Its empirical formula is C43H51N3O11 and its molecular weight is 785.9 Da; the chemical structure is shown in Figure 128.1.",

author = "Samar Ojaimi and Korman, \{Tony M.\}",

year = "2017",

month = oct,

day = "2",

language = "English",

isbn = "9781498747950",

pages = "2450--2462",

editor = "Grayson, \{M. Lindsay \}",

booktitle = "Kucers the Use of Antibiotics",

publisher = "CRC Press",

address = "Australia",

edition = "7th ",

}

TY - CHAP

T1 - Rifaximin

AU - Ojaimi, Samar

AU - Korman, Tony M.

PY - 2017/10/2

Y1 - 2017/10/2

N2 - Rifaximin (4-deoxy-4'-methylpyrido[1',2'-1,2]imidazole- [5,4c]-rifamycin SV) is a synthetic antimicrobial and derivative of rifamycin (Jiang and DuPont, 2005; Scarpignato and Pelosini, 2005; Finegold et al., 2009). It was first described as compound L-105 in 1982 and marketed in Italy in 1987 (Huang and DuPont, 2005; Scarpignato and Pelosini, 2005). Its empirical formula is C43H51N3O11 and its molecular weight is 785.9 Da; the chemical structure is shown in Figure 128.1.

AB - Rifaximin (4-deoxy-4'-methylpyrido[1',2'-1,2]imidazole- [5,4c]-rifamycin SV) is a synthetic antimicrobial and derivative of rifamycin (Jiang and DuPont, 2005; Scarpignato and Pelosini, 2005; Finegold et al., 2009). It was first described as compound L-105 in 1982 and marketed in Italy in 1987 (Huang and DuPont, 2005; Scarpignato and Pelosini, 2005). Its empirical formula is C43H51N3O11 and its molecular weight is 785.9 Da; the chemical structure is shown in Figure 128.1.

UR - https://www.scopus.com/pages/publications/85056691146

M3 - Chapter (Book)

AN - SCOPUS:85056691146

SN - 9781498747950

SP - 2450

EP - 2462

BT - Kucers the Use of Antibiotics

A2 - Grayson, M. Lindsay

PB - CRC Press

CY - Boca Raton FL USA

ER -

Rifaximin

Abstract

Other files and links

Cite this